[{"address1": "727 North Ann Arbor", "city": "Oklahoma City", "state": "OK", "zip": "73127", "country": "United States", "phone": "405 942 3040", "fax": "405 942 5471", "website": "https://www.pdrx.com", "industry": "Medical Distribution", "sector": "Healthcare", "longBusinessSummary": "PD-Rx Pharmaceuticals, Inc. engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States. The company offers prepackaged medications, such as creams, ointments, ophthalmics, otics, liquids, and suspensions products; and packaging services. It also provides dispensing platform, a manual dispensing system that provides 10 recordkeeping labels to match the 10 bottle trays as handling package; and PD-Rx Net, a web-based application designed to track prescriptions filled at the point of care and print prescription labels for prescription that are filled onsite. In addition, the company offers physician, primary care, urgent care, pain management, occupational, orthopedic, bariatric, and dental physical dispensing services. It serves its products to physicians, pharmacies, and medical clinics. PD-Rx Pharmaceuticals, Inc. was incorporated in 1986 and is headquartered in Oklahoma City, Oklahoma.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Robert D. Holsey D.O., R.Ph.", "age": 70, "title": "Chairman, CEO & President", "yearBorn": 1953, "fiscalYear": 1999, "totalPay": 58519, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert L. Baker CPA", "age": 74, "title": "CFO, Treasurer & Director", "yearBorn": 1949, "fiscalYear": 1999, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jack L. McCall II", "age": 63, "title": "COO, Executive VP of Marketing & Sales, Secretary and Director", "yearBorn": 1960, "fiscalYear": 1999, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert L. Surovec", "age": 74, "title": "Regulatory Affairs Compliance Officer", "yearBorn": 1949, "fiscalYear": 1999, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 946598400, "maxAge": 86400, "priceHint": 4, "previousClose": 3.75, "open": 3.75, "dayLow": 3.75, "dayHigh": 3.75, "regularMarketPreviousClose": 3.75, "regularMarketOpen": 3.75, "regularMarketDayLow": 3.75, "regularMarketDayHigh": 3.75, "exDividendDate": 1544659200, "beta": 1120692.5, "trailingPE": 3.2962961, "volume": 998, "regularMarketVolume": 998, "averageVolume": 118, "marketCap": 6105720, "fiftyTwoWeekLow": 3.5, "fiftyTwoWeekHigh": 7.5, "priceToSalesTrailing12Months": 0.28703606, "fiftyDayAverage": 3.7008, "twoHundredDayAverage": 5.2923, "currency": "USD", "enterpriseValue": 6253202, "profitMargins": -0.00461, "sharesOutstanding": 1715090, "bookValue": 6.841, "priceToBook": 0.52039176, "lastFiscalYearEnd": 1688083200, "nextFiscalYearEnd": 1719705600, "mostRecentQuarter": 946598400, "earningsQuarterlyGrowth": 0.066, "netIncomeToCommon": -98064, "trailingEps": 1.08, "enterpriseToRevenue": 0.294, "enterpriseToEbitda": -121.613, "exchange": "OEM", "quoteType": "EQUITY", "symbol": "PDRX", "underlyingSymbol": "PDRX", "shortName": "PD-RX PHARMACEUTICALS INC", "longName": "PD-Rx Pharmaceuticals, Inc.", "firstTradeDateEpochUtc": 952612200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "950d4dff-1d45-383e-a8e8-f4ea1432e6c9", "gmtOffSetMilliseconds": -14400000, "currentPrice": 3.56, "recommendationKey": "none", "totalCash": 104552, "totalCashPerShare": 0.064, "ebitda": -51419, "totalDebt": 466840, "quickRatio": 5.427, "currentRatio": 6.712, "totalRevenue": 21271614, "debtToEquity": 31.306, "revenuePerShare": 13.015, "returnOnAssets": -0.0091, "returnOnEquity": -0.00868, "freeCashflow": 1382766, "operatingCashflow": 1788703, "earningsGrowth": 0.604, "revenueGrowth": -0.025, "grossMargins": 0.31559, "ebitdaMargins": -0.00242, "operatingMargins": 0.02181, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]